Crossmark

Luteolin ameliorates diabetic retinopathy through activation of the Nrf2/Keap1 and SIRT3/AMPK antioxidant axes and suppression of cGAS-STING and Wnt/β-catenin pathways in experimental rats

Crossref DOI link: https://doi.org/10.1007/s13105-026-01170-6

Published Online: 2026-03-07

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Ruiwen

Guo, Kangjie

Li, Jianchao
Funding

Funding for this research was provided by:

Project of the Key Research Laboratory on Concurrent Treatment of Blood

Water for Eye Diseases by the Shaanxi Administration of Traditional Chinese Medicine
License Information

Text and Data Mining valid from 2026-03-07

Version of Record valid from 2026-03-07
More Information

Article History

Received: 29 October 2025

Accepted: 23 February 2026

First Online: 7 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below